 |
|
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
Clin Mol Hepatol. 2020;26(4):480-483. Published online 2020 Sep 21 DOI: https://doi.org/10.3350/cmh.2020.0208
|
|
Citations to this article as recorded by
 Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma
Jeong Hyun Lee, Jeong Ah Hwang, Kyowon Gu, Jaeseung Shin, Seungchul Han, Young Kon Kim
Magnetic Resonance Imaging.2024; 109: 127. CrossRef Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim
European Journal of Gastroenterology & Hepatology.2023; 35(2): 191. CrossRef Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy
Yang Lu, Shuang Ren, Jianning Jiang
BMC Surgery.2023;[Epub] CrossRef Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Clinical and Molecular Hepatology.2023; 29(3): 593. CrossRef Diagnosis of primary clear cell carcinoma of the liver based on Faster region-based convolutional neural network
Bin Liu, Jianfei Li, Xue Yang, Feng Chen, Yanyan Zhang, Hongjun Li
Chinese Medical Journal.2023; 136(22): 2706. CrossRef Ketogenic Diets and Hepatocellular Carcinoma
Yan Lan, Chaonan Jin, Pavitra Kumar, Xia Yu, Cameron Lenahan, Jifang Sheng
Frontiers in Oncology.2022;[Epub] CrossRef Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy
Jie Zhang, Shang Dong Qin, Yan Li, Fei Lu, Wen Feng Gong, Jian Hong Zhong, Liang Ma, Jing Fei Zhao, Guo Hua Zhan, Peng Zhan Li, Bin Song, Bang De Xiang
World Journal of Surgical Oncology.2022;[Epub] CrossRef Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
Pil Soo Sung, Ji Won Han, Changho Seo, Joseph Ahn, Soon Kyu Lee, Hee Chul Nam, Ho Joong Choi, Young Kyoung You, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Frontiers in Pharmacology.2021;[Epub] CrossRef Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
Chao-Wei Lee, Sey-En Lin, Ming-Chin Yu, Hao-Wei Kou, Cheng-Han Lee, Tony Kuo, Kuan-Chieh Lee, Hsin-I Tsai
Journal of Personalized Medicine.2021; 11(11): 1078. CrossRef Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
International Journal of Molecular Sciences.2021; 22(19): 10271. CrossRef
|